Effects of Denosumab on the Pharmacokinetics of Etanercept

NCT01294397 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of enrollment.

Conditions

Postmenopausal
Osteopenia
Rheumatoid Arthritis
Osteoporosis

Interventions

DRUG: Etanercept
DRUG: Denosumab

Sponsor

Amgen